Arcturus Therapeutics Holdings (ARCT) Retained Earnings: 2018-2025
Historic Retained Earnings for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Sep 2025 value amounting to -$485.5 million.
- Arcturus Therapeutics Holdings' Retained Earnings fell 15.93% to -$485.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$485.5 million, marking a year-over-year decrease of 15.93%. This contributed to the annual value of -$448.8 million for FY2024, which is 21.99% down from last year.
- According to the latest figures from Q3 2025, Arcturus Therapeutics Holdings' Retained Earnings is -$485.5 million, which was down 2.85% from -$472.1 million recorded in Q2 2025.
- In the past 5 years, Arcturus Therapeutics Holdings' Retained Earnings ranged from a high of -$200.2 million in Q1 2021 and a low of -$485.5 million during Q3 2025.
- For the 3-year period, Arcturus Therapeutics Holdings' Retained Earnings averaged around -$404.2 million, with its median value being -$411.9 million (2024).
- Per our database at Business Quant, Arcturus Therapeutics Holdings' Retained Earnings tumbled by 177.78% in 2021 and then rose by 27.92% in 2023.
- Quarterly analysis of 5 years shows Arcturus Therapeutics Holdings' Retained Earnings stood at -$347.5 million in 2021, then grew by 2.69% to -$338.1 million in 2022, then declined by 8.80% to -$367.9 million in 2023, then fell by 21.99% to -$448.8 million in 2024, then fell by 15.93% to -$485.5 million in 2025.
- Its last three reported values are -$485.5 million in Q3 2025, -$472.1 million for Q2 2025, and -$462.9 million during Q1 2025.